Pharmaceutical Products Recalled From The Lebanese Market According To Minister's Decision No.592/1

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L01XA03	OXALIPLATINO GP PHARM	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder for solution	2,957,797 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder for solution	2,957,797 L.L
J05AB01	ASIMPLEX	G	Aciclovir - 250mg	250mg	Injectable lyophilised powder for solution	278,175 L.L
L01XG01	VELCADE	B	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	23,616,000 L.L
A16AB02	CEREZYME	B	Imiglucerase - 400IU	400IU	Injectable lyophilised powder for solution	128,412,818 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	14,169,600 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
J05AB16	FLEXIVIR	G	Remdesivir - 50mg	50mg	Injectable lyophilised powder for solution	4,837,833 L.L
L01XX02	ERWINASE	BioTech	Erwinia L-asparaginase - 10,000IU	10,000IU	Injectable lyophilised powder for solution	444,434,845 L.L
L01DC01	BLEOCIN	B	Bleomycin (sulfate), - 15mg	15mg	Injectable lyophilised powder for solution	2,109,833 L.L
J01AA12	TYGACIL	B	Tigecycline - 50mg	50mg	Injectable lyophilised powder for solution	25,356,524 L.L
J01AA12	TAGIX	G	Tigecycline - 50mg	50mg	Injectable lyophilised powder for solution	2,436,386 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	L.L
J07BD52	PRIORIX	B	Rubella virus live attenuated - ?10³ CCID50, Mumps virus live attenuated - ?103.7 CCID50, Measles virus live attenuated - ?10³ CCID50		Injectable lyophilised powder for solution+diluent	1,142,266 L.L
J07BK01	VARILRIX + SOLVENT IN SYRINGE	B	Varicella virus, live attenuated - ?1033 PFU	?1033 PFU	Injectable lyophilised powder for solution+diluent	3,473,833 L.L
B02BD02	XYNTHA	BioTech	Moroctocog alfa - 500IU	500IU	Injectable lyophilised powder for solution+diluent	L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,561,486 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU		Injectable lyophilised powder for solution+diluent	L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,247,110 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	27,354,631 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	26,495,478 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	47,481,122 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	46,817,511 L.L
B02BD02	XYNTHA	BioTech	Moroctocog alfa - 500IU	500IU	Injectable lyophilised powder for solution+diluent	23,067,288 L.L
B02BD04	IMMUNINE	BioHuman	Plasma coagulation factor IX, human - 600IU	600IU	Injectable lyophilised powder for solution+diluent	20,506,214 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 600IU, Blood Coagulation Factor VIII - 250IU		Injectable lyophilised powder for solution+diluent	14,117,737 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 2400IU, Blood Coagulation Factor VIII - 1000IU		Injectable lyophilised powder for solution+diluent	49,643,758 L.L
J01DD01	CEFOTAX	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	217,702 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU		Injectable lyophilised powder for solution+diluent	33,698,319 L.L

المستحضرات الصيدلانية التي تمّ سحبها من الأسواق اللبنانية بناءً على قرار الوزير رقم 1/592 تاريخ 8/4/2019